82 related articles for article (PubMed ID: 7510612)
1. Anti-HIV vaccines. Current status and future developments.
Norley SG; Vogel T; Kurth R
Drugs; 1993 Dec; 46(6):947-60. PubMed ID: 7510612
[No Abstract] [Full Text] [Related]
2. Comparative approach to retroviral vaccines.
Burny A
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):389-92. PubMed ID: 8882316
[No Abstract] [Full Text] [Related]
3. SIV infection of macaques: a model for AIDS vaccine development.
Gardner MB
Dev Biol Stand; 1990; 72():259-66. PubMed ID: 2178124
[TBL] [Abstract][Full Text] [Related]
4. Simian retrovirus vaccines: simian retrovirus and simian immunodeficiency lentivirus.
Gardner MB; Luciw PA; Sawai ET; Marthas ML; Miller CJ; McChesney MB; Lerche NW; Pedersen NC
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):399-401. PubMed ID: 8882318
[No Abstract] [Full Text] [Related]
5. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
Biberfeld G; Thorstensson R; Putkonen P
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
[No Abstract] [Full Text] [Related]
6. Antibodies and resistance to natural HIV infection.
Nabel GJ; Sullivan NJ
N Engl J Med; 2000 Oct; 343(17):1263-5. PubMed ID: 11071680
[No Abstract] [Full Text] [Related]
7. HIV vaccination dilemma.
Sabin AB
Nature; 1993 Mar; 362(6417):212. PubMed ID: 8318105
[No Abstract] [Full Text] [Related]
8. Long-term protection of macaques against high-dose type D retrovirus challenge after immunization with recombinant vaccinia virus expressing envelope glycoproteins.
Benveniste RE; Kuller L; Roodman ST; Hu SL; Morton WR
J Med Primatol; 1993; 22(2-3):74-9. PubMed ID: 8411111
[TBL] [Abstract][Full Text] [Related]
9. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO
Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
[No Abstract] [Full Text] [Related]
10. Primate models of AIDS vaccine development.
Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
[No Abstract] [Full Text] [Related]
11. Concerning the anti-major histocompatibility complex approach to HIV type 1 vaccine design.
Luscher MA; Dela Cruz CS; MacDonald KS; Barber BH
AIDS Res Hum Retroviruses; 1998 May; 14(7):541-4. PubMed ID: 9591707
[No Abstract] [Full Text] [Related]
12. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
13. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.
Warren JT; Dolatshahi M
J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110
[No Abstract] [Full Text] [Related]
14. Current world literature.
Curr Opin HIV AIDS; 2011 Jan; 6(1):86-9. PubMed ID: 21228756
[No Abstract] [Full Text] [Related]
15. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
[TBL] [Abstract][Full Text] [Related]
16. Prospects for live attenuated HIV.
Desrosiers RC
Nat Med; 1998 Sep; 4(9):982. PubMed ID: 9734368
[No Abstract] [Full Text] [Related]
17. Humoral immunity to HIV, SIV, and SHIV.
Haigwood NL; Zolla-Pazner S
AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
[No Abstract] [Full Text] [Related]
18. Search for AIDS vaccine advances.
Hum Vaccin Immunother; 2012 Feb; 8(2):151. PubMed ID: 22745942
[No Abstract] [Full Text] [Related]
19. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK
J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554
[TBL] [Abstract][Full Text] [Related]
20. [HIV vaccine].
Matano T
Nihon Rinsho; 2005 May; 63 Suppl 5():659-65. PubMed ID: 15954426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
